CIK 0001175151
- Non-accelerated filer
- Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980373793
- Phone
- +1 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,300)
- 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,250)
- 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,690)
- 4 Conversion President and CEO acquired 1,061,354 shares (conversion)
- 4 Conversion Director acquired 44,075.48 shares (conversion)
- 4 Open-market sale Director sold 100,000 shares at $0.24 ($24,250)
- 4 Open-market sale Director sold 100,000 shares at $0.24 ($24,100)
- 4 Open-market sale Director sold 143,787 shares at $0.24 ($34,509)
- 4 Open-market sale Director sold 50,000 shares at $0.24 ($11,840)
- 4 Open-market sale Director sold 1,240,762 shares at $0.24 ($297,783)
- 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,405)
- 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,275)
- 4 Open-market sale Director sold 41,500 shares at $0.23 ($9,358)
- 4 Open-market sale Director sold 8,500 shares at $0.23 ($1,920)
- 4 Open-market sale Director sold 17,600 shares at $0.24 ($4,224)
- 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,430)
- 4 Open-market sale Director sold 30,450 shares at $0.24 ($7,308)
- 4 Open-market sale Director sold 100,000 shares at $0.24 ($24,000)
- 4 Open-market sale Director sold 50,000 shares at $0.23 ($11,430)
Page 14 of 20 · 395 filings